Report Library
View More
Acute Lymphoblastic Leukemia KOL In...
March 30, 2026
Acute Lymphoblastic Leukemia KOL In...
March 30, 2026
Datamonitor Healthcare CV&Met: Veno...
March 10, 2026
Datamonitor Healthcare CV&Met: Atri...
March 10, 2026
Datamonitor Healthcare Oncology: Sm...
March 10, 2026
Datamonitor Healthcare I&I: Glaucom...
March 10, 2026
Bio Asia 2026 Conference Dispatch
March 9, 2026
Datamonitor Healthcare CV&Met: Isch...
March 4, 2026
Datamonitor Healthcare CV&Met: Chem...
March 4, 2026
Datamonitor Healthcare Other: Erect...
March 4, 2026
Datamonitor Healthcare Other: Hypog...
March 4, 2026
Datamonitor Healthcare CV&Met: Amyl...
March 4, 2026
Datamonitor Healthcare Oncology: Tu...
March 4, 2026
Datamonitor Healthcare CNS: Neuropa...
March 4, 2026
Datamonitor Healthcare Oncology: Me...
March 4, 2026
Cystic Fibrosis (CF) KOL Interview ...
March 2, 2026
Neuroendocrine Tumors (NET) KOL Int...
March 1, 2026
Neuroendocrine Tumors (NET) KOL Int...
March 1, 2026
Neuroendocrine Tumors (NET) KOL Int...
February 27, 2026
Neuroendocrine Tumors (NET) KOL Int...
February 27, 2026
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 3/29/26 | Merck & Co. (MRK) | Winrevair for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/26/26 | Maze Therapeutics (MAZE) | MZE829 for Chronic Kidney Disease (CKD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/23/26 | Valneva (VLA) | VLA15 for Antibacterial and Antifungal - Miscellaneous Vaccines and Treatments | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/21/26 | Dizal Pharmaceutical (688192) | Zegfrovy for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 3/19/26 | Causeway Therapeutics | TenoMiR for Orthopedic Disorder | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |